A pairing appears on this page only when a trial gave both ingredients together and measured the result. Thymoquinone has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
A 2026 laboratory report paired glycine with thymoquinone and found the combination acted on glucose-related endpoints more than either alone in that model. Both molecules independently touch oxidative stress handling, which is the proposed common thread. This was a laboratory model and the endpoints were markers, so it does not carry over to people without human work.
Thymoquinone is lipophilic and concentrates in the lipid phase, the same compartment where alpha-tocopherol does its chain-breaking work. Two chain-breaking antioxidants in one compartment spare each other, so less of each is consumed per unit of oxidative load. The evidence for this specific pair is mechanistic rather than clinical.
The quinone carbonyls accept electrons and the molecule cycles between quinone and hydroquinone forms, consuming reduced glutathione in the process. At low concentrations that cycling activates Nrf2-driven antioxidant enzyme expression, which raises glutathione synthesis over time. At high concentrations the same chemistry depletes the pool instead, so the direction is dose-dependent and not one-way.
N-acetylcysteine supplies cysteine for glutathione synthesis, which offsets the thiol consumption driven by quinone cycling. The flip side is that a free thiol adds directly across the quinone in solution, so mixing them in the same liquid formulation can consume the active before it is swallowed. The interaction is favourable metabolically and unfavourable in the bottle.
As a lipophilic quinone it needs a lipid phase to stay dissolved through the gut and to enter mixed micelles. Medium-chain triglycerides disperse readily and are the common carrier in softgel formats. This is why capsule oil formats and dry powder formats are not interchangeable at the same stated milligram.
Lecithin forms mixed micelles and liposomal structures that hold lipophilic molecules in a dispersible state. Applied to black seed oil formats, it keeps the active from separating and improves how evenly it disperses in gut contents. Formulation reasoning, with black seed oil delivery data still limited.
Both compounds activate Nrf2-driven antioxidant response elements and both damp NF-kB signalling in laboratory systems. Combining them broadens the phenolic profile without stacking a single molecule. Nearly all of the supporting work is in cells and animals, and both molecules absorb poorly without a lipid or delivery aid.
Lipoic acid moves between water and lipid compartments and helps regenerate oxidised glutathione and tocopherol. That supports the thiol pool that quinone cycling draws down. The pairing is mechanistically coherent and has not been tested together in people.
A redox-cycling quinone in the presence of free iron can generate hydroxyl radicals rather than scavenge them, flipping an antioxidant into a pro-oxidant in the same test system. The chemistry is well described for quinones as a class. Taking a high-dose iron and a quinone-rich oil at the same moment is worth spacing on that basis alone.
Nothing specific on file for Thymoquinone. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 10 we read for Thymoquinone. The full linked list is below.
11 sources behind our Thymoquinone verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 25 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Thymoquinone is, not how risky it is. A report is not proof Thymoquinone caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.